Stock Screener App

Gratuito -

Installare

2.72

1.09% -0.03

C 4 Therapeutics Inc (CCCC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

C 4 Therapeutics Inc Azioni (CCCC) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	1.91% 11.02	11.23	6.463	7.238	15.36
Operating Expenses	25.15% 34.16	45.64	34.96	36.40	43.61
Benefits Costs and Expenses	27.69% 31.38	43.40	32.48	33.56	40.03
Costs And Expenses	27.69% 31.38	43.40	32.48	33.56	40.03
Operating Income/Loss	32.74% -23.14	-34.41	-28.50	-29.16	-28.24
Nonoperating Income/Loss	23.78% 2.78	2.246	2.481	2.842	3.578
Income/Loss From Continuing Operations Before Tax	36.69% -20.36	-32.17	-26.02	-26.32	-24.67
Income Tax Expense/Benefit	0.121	-	-	-	-
Income/Loss From Continuing Operations After Tax	36.31% -20.49	-32.17	-26.02	-26.32	-24.67
Net Income/Loss	36.31% -20.49	-32.17	-26.02	-26.32	-24.67
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	84.26% 11.42	72.56	71.01	70.83	69.63
Diluted Average Shares	84.26% 11.42	72.56	71.01	70.83	69.63
Basic Earnings Per Share	79.55% -0.09	-0.44	-0.37	-0.37	-0.35
Diluted Earnings Per Share	79.55% -0.09	-0.44	-0.37	-0.37	-0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters